Pharmalot… Pharmalittle… Good Evening

1 Comment

sleep-tightAnd so another busy day comes to a close. Since we were occupied with sundry tasks late this afternoon, we thought you may appreciate getting caught up with a few headlines that passed under our nose. Thanks for stopping by today and we hope you have a pleasant evening…

FDA Panel Backs New Version Of Genzyme Drug (Yahoo/AP)

FDA Extends Review Of Pfizer Osteoporosis Drug (Reuters)

Sandoz Loses Bid To Sell Generic Biaxin (Bloomberg News)

Glaxo Pays $170M For OTC Oral Healthcare Company (Reuters)

Jump to comments

Share

Comments

  1. Concerning the New Version of Genzyme:

    “The FDA decided the new version would have to be evaluated as a separate product because of major differences in the manufacturing process.”

    As it should be.

    G’night to you, Ed.

Leave a Comment

Subscribe

RSS Feed

Comments feed for this post only.

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/

-->